Keith C. Ferdinand MD
Nuclear Cardiology, Preventive Cardiology
Professor, Medicine, Tulane University School of Medicine
Join to View Full Profile
1430 Tulane Ave# 8548New Orleans, LA 70112
Phone+1 504-988-6113
Fax+1 504-582-7973
Dr. Ferdinand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Howard UniversityFellowship, Cardiovascular Disease, 1981
Louisiana State University (Shreveport)Residency, Internal Medicine, 1977 - 1980
US Public Health Service HospitalInternship, Transitional Year, 1976 - 1977
Howard University College of MedicineClass of 1976
Certifications & Licensure
LA State Medical License 1976 - 2025
GA State Medical License 2006 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) Start of enrollment: 2002 Mar 01
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- Combating cardiovascular disease disparities: The potential role of artificial intelligence.Chisom J Orakwue, Farbod Zahedi Tajrishi, Constance M Gistand, Han Feng, Keith C Ferdinand
American Journal of Preventive Cardiology. 2025-06-01 - Aprocitentan for Blood Pressure Reduction in Black Patients.John M Flack, Markus P Schlaich, Michael A Weber, Mouna Sassi-Sayadi, Krzysztof Narkiewicz
Hypertension. 2025-04-01 - Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial.John H Alexander, Elizabeth J Lydon, Jonathan P Piccini, Thomas Viethen, Jonas Oldgren
JAMA Cardiology. 2025-03-26
Authored Content
- African-American COVID-19 Mortality A Sentinel EventJune 2020
- African-American COVID-19 Mortality A Sentinel EventJune 2020
- Off Script: Black Lives, COVID-19, Katrina, and Social Justice—Time for Healers to Step UpJune 2020
- Hypertension Across a Woman’s Life CycleApril 2018
- Join now to see all
Press Mentions
American College of Cardiology Honors 21 Distinguished Award RecipientsMarch 28th, 2025- High BP While Lying down Signals Future CVD RiskJanuary 22nd, 2025
- Dual-Medication Polypills Effectively Lowered Blood Pressure Among South Asian AdultsNovember 18th, 2024
- Join now to see all
Grant Support
- Church Wellness Coordinator-led Intervention to Improve Hypertension Control in the Black CommunityTULANE UNIVERSITY OF LOUISIANA2022–2027
- Community Health Worker-Led Church-Based Intervention for Eliminating Cardiovascular Health Disparities in African AmericansTULANE UNIVERSITY OF LOUISIANA2020–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
